We are live on
!
Find out more
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
68 hedge funds and large institutions have $53.1M invested in Novelion Therapeutics Inc. Common Shares in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
13% more capital invested
Capital invested by funds: $47.1M → $53.1M (+$5.97M)
17% less funds holding
Funds holding: 82 → 68 (-14)
25% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 20
54% less call options, than puts
Call options by funds: $69K | Put options by funds: $149K
88% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 16
Holders
68
Holders Change
-14
Holders Change %
-17.07%
% of All Funds
1.56%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
2
Increased
15
Reduced
20
Closed
16
Calls
$69K
Puts
$149K
Net Calls
-$80K
Net Calls Change
-$27K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.77M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$701K |
| 3 |
State Street
Boston,
Massachusetts
|
+$114K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$65.4K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$64.7K |
Top Sellers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$779K |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$269K |
| 3 |
Charles Schwab
San Francisco,
California
|
-$163K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$138K |
| 5 |
VF
Virtu Financial
New York
|
-$138K |
